Physicians' Academy for Cardiovascular Education
Agenda: Managing CKD, Diabetes & CVD:  Is epigenetics a new way forward?

Agenda: Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?

Managing CKD, Diabetes & CVD: Is epigenetics a new way forward? BET inhibition, ERA-EDTA 2017, Madrid Spain

Introduction

The aim of this educational programme was to provide a balanced overview on a novel approach to reduce residual CV risk in patients with increase cardiovascular and renal risk, namely BET inhibition. BET refers to a bromodomain and extra-terminal domain of regulatory proteins. Its inhibition modifies gene expression via epigenetic mechanisms.. This symposium was held during the 54th ERA EDTA Congress in Madrid, Spain on June 5, 2017

Educational objectives

Agenda

Co-chairman

Topics

CME accreditation

This programme was accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit

Funding

The symposium was supported by an unrestricted educational grant from Resverlogix Corp